WALD Stock Overview
Operates in the beauty and wellness industry. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Waldencast plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.24 |
| 52 Week High | US$12.00 |
| 52 Week Low | US$2.41 |
| Beta | -0.53 |
| 11 Month Change | -3.28% |
| 3 Month Change | 5.88% |
| 1 Year Change | -65.05% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -57.98% |
Recent News & Updates
Recent updates
Waldencast plc (NASDAQ:WALD) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Aug 13
Waldencast Plc: Investors Continue To Demand More Growth
Jun 28We Think Waldencast (NASDAQ:WALD) Has A Fair Chunk Of Debt
Jun 19Waldencast plc (NASDAQ:WALD) Shares Slammed 29% But Getting In Cheap Might Be Difficult Regardless
May 11Waldencast plc's (NASDAQ:WALD) Intrinsic Value Is Potentially 55% Above Its Share Price
Apr 07Is Waldencast plc (NASDAQ:WALD) Trading At A 42% Discount?
Dec 14Waldencast Acquisition reports Q2 results; reaffirms FY22 guidance
Aug 11Shareholder Returns
| WALD | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -4.7% | -0.2% | -1.2% |
| 1Y | -65.0% | -13.3% | 30.4% |
Return vs Industry: WALD underperformed the US Personal Products industry which returned -13.3% over the past year.
Return vs Market: WALD underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| WALD volatility | |
|---|---|
| WALD Average Weekly Movement | 10.5% |
| Personal Products Industry Average Movement | 8.4% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: WALD's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: WALD's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 284 | Michel Brousset | www.waldencast.com |
Waldencast plc operates in the beauty and wellness industry. It engages in developing, acquiring, accelerating, and scaling various brands. The company provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Waldencast plc Fundamentals Summary
| WALD fundamental statistics | |
|---|---|
| Market cap | US$397.43m |
| Earnings (TTM) | -US$70.64m |
| Revenue (TTM) | US$240.38m |
1.5x
P/S Ratio-5.1x
P/E RatioIs WALD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WALD income statement (TTM) | |
|---|---|
| Revenue | US$240.38m |
| Cost of Revenue | US$72.81m |
| Gross Profit | US$167.58m |
| Other Expenses | US$238.22m |
| Earnings | -US$70.64m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 20, 2024
| Earnings per share (EPS) | -0.64 |
| Gross Margin | 69.71% |
| Net Profit Margin | -29.39% |
| Debt/Equity Ratio | 22.6% |
How did WALD perform over the long term?
See historical performance and comparison